ORUDIS Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Orudis, and what generic alternatives are available?

Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.

The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Orudis

A generic version of ORUDIS was approved as ketoprofen by TEVA on December 22^nd, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ORUDIS?
What are the global sales for ORUDIS?
What is Average Wholesale Price for ORUDIS?

Summary for ORUDIS

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	164
Clinical Trials:	2
DailyMed Link:	ORUDIS at DailyMed

Drug patent expirations by year for ORUDIS

Recent Clinical Trials for ORUDIS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mae Stone Goode Foundation	Phase 2/Phase 3
University of Rochester	Phase 2/Phase 3
Sanford Research	Early Phase 1

See all ORUDIS clinical trials

US Patents and Regulatory Information for ORUDIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-001	Jul 31, 1987		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Cons	ORUDIS KT	ketoprofen	TABLET;ORAL	020429-001	Oct 6, 1995		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-002	Jan 9, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-003	Jan 9, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ORUDIS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-001	Jul 31, 1987	⤷ Sign Up	⤷ Sign Up
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-003	Jan 9, 1986	⤷ Sign Up	⤷ Sign Up
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-002	Jan 9, 1986	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ORUDIS

See the table below for patents covering ORUDIS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Switzerland	505050	Procédé de préparation des dérivés de l'acide benzoyl-3 hydroxy-2 phényl acétique	⤷ Sign Up
Malaysia	7300143	(3-BENZOYLPHENYL) ALKONOIC ACIDS	⤷ Sign Up
Luxembourg	60059		⤷ Sign Up
U.S.S.R.	544364		⤷ Sign Up
Switzerland	487105	Procédé de préparation de nouveaux dérivés de l'acide benzoyl-3 phénylacétique	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ORUDIS

Recent Clinical Trials for ORUDIS

Make Better Decisions: Try a trial or see plans & pricing